The kit is being designed for the INSPIRA™ ART device series and
is intended to be compatible with various life support machines
sold in the market
RA'ANANA, Israel, Jan. 9, 2024 /PRNewswire/ -- Inspira
Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW)
(the "Company" or "Inspira"), a pioneer in life support technology
with a vision to supersede traditional mechanical ventilators,
today announced its plan to launch a single-use disposable blood
oxygenation kit (the "Kit"), currently in development, for its
INSPIRA ART medical device series. The Kit is also intended to be
compatible with various other life support machines, tapping into
the disposable perfusion systems market.
The Kit, anticipated to be submitted for US Food & Drug
Administration (FDA) authorization in 2025, is a single-use product
designed for efficient blood oxygenation and carbon dioxide
removal. The Kit represents a strategic move to enhance hospital
budget spending by potentially reducing costs. The Company is
focusing on making the Kit compatible with other medical devices
such as certain types of cardio-pulmonary bypass machines.
Dagi Ben-Noon, CEO of Inspira Technologies, commented:
"Introducing the Kit marks the potential expansion of our market
presence and fast-tracks our goal to deploy our blood oxygenation
devices, with potential revenue streams based on the disposable
razorblade business model. We believe that this development, along
with the anticipated FDA clearance of our INSPIRA™ ART100 device in
the first half of 2024, solidifies our commitment to providing
comprehensive and affordable solutions in life support
technology."
Inspira Technologies OXY B.H.N Ltd.
Inspira Technologies is leading the way in transforming
life-support care. Its innovative solutions are paving the way for
direct blood oxygenation, bypassing the lungs, and potentially
reducing the need for traditional mechanical ventilation. Beyond
this, the Company is committed to advancing blood circulation
technology and incorporating AI-driven monitoring systems. These
advancements are part of its strategy to offer more
patient-focused, data-informed care. The integration of these
technologies signifies the potential to enhance patient outcomes
and streamline hospital operations, marking a new era in
respiratory care.
For more information, please visit our corporate website:
https://inspira-technologies.com/
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking
statements under U.S. Federal securities laws. These
forward-looking statements and their implications are based only on
the current expectations of the management of the Company. They are
subject to several factors and uncertainties that could cause
results to differ materially from those described in the
forward-looking statements. For example, the Company uses
forward-looking statements when it discusses the prospective
compatibility of the Kit with other life support machines, the
anticipated FDA submission of the Kit in 2025, that the Kit
represents a strategic move to potentially reduce costs, that the
Kit fast-tracks the Company's goal to deploy its blood oxygenation
devices, and the belief that the Kits, along with the anticipated
FDA clearance of its INSPIRA ART device in the first half of 2024,
solidifies its commitment to providing comprehensive and affordable
solutions in life support technology. Except as otherwise required
by law, the Company undertakes no obligation to publicly release
any revisions to these forward-looking statements to reflect events
or circumstances after the date hereof or the occurrence of
unanticipated events. More detailed information about the risks and
uncertainties affecting the Company is contained under the heading
"Risk Factors" in the Company's annual report on Form 20-F for the
fiscal year ended December 31, 2022,
filed with the SEC, which is available on the SEC's website,
http://www.sec.gov.
For more details:
Public Relations Manager
Adi Shmueli
Inspira Technologies
info@inspirao2.com
+972-9-9664485
Logo -
https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg
Copyright © 2018-2024 Inspira Technologies OXY B.H.N. LTD., All
rights reserved.
View original
content:https://www.prnewswire.com/news-releases/inspira-announces-plans-to-launch-and-target-single-use-disposable-blood-oxygenation-kit-for-a-new-disposable-perfusion-market-opportunity-302029857.html
SOURCE Inspira Technologies